Advances in antiretroviral treatment have transformed HIV from a terminal diagnosis into a manageable chronic condition for many people. That success has also brought a clearer view of another serious and preventable health threat: smoking.

People with HIV now lose more years of life to smoking than to HIV itself, according to researchers and clinicians interviewed by the University of Rhode Island. The issue is substantial in the United States, where about 1.2 million people are living with HIV. While the national adult smoking rate has fallen below 10% for the first time, smoking among people with HIV can be as much as four times higher.

The contrast highlights an important public-health gap. Longer lives made possible by effective HIV care are a major achievement, but they also make reducing the long-term harms of tobacco more urgent. The authors argue that smoking cessation cannot be treated as an afterthought in HIV care.

Why standard approaches may not be enough

Many people with HIV want to stop smoking, yet their quit rates are lower than those seen in the general population. Traditional approaches, including counseling and medication, can be helpful, but people with HIV tend to have worse outcomes with those methods, the article says.

That does not mean cessation efforts should be abandoned. It means the care offered needs to account for the circumstances that can make quitting especially difficult. Smoking is not solely a matter of nicotine dependence. For some people, it is also tied to stress management and to the pressures surrounding an HIV diagnosis.

Researchers Lauren Pacek of the Rutgers Health Institute for Nicotine and Tobacco Studies and Patricia Cioe of the University of Rhode Island College of Nursing described overlapping obstacles that can complicate efforts to quit. People with HIV may also be managing anxiety, depression, diabetes, hypertension and other concerns. In a time-limited clinical appointment, tobacco cessation counseling can struggle for attention alongside those immediate needs.

Stress, poverty, stigma and loneliness can also be associated with an HIV diagnosis. In that setting, smoking may serve as a coping mechanism even when a person understands its health risks and wants to quit. A one-size-fits-all intervention may fail to address the reasons tobacco use remains embedded in daily life.

Expanding the cessation toolkit

The central recommendation is pragmatic: health-care teams should offer as many evidence-based paths to cessation as possible. The article calls for moving beyond a “more of the same” approach, particularly for patients who have not succeeded with conventional counseling or medication.

A broader toolkit begins with recognizing that smoking cessation is part of long-term HIV care, not a separate issue to be raised only occasionally. It also requires clinicians to understand that patients may be balancing several medical conditions and difficult social circumstances at once.

In practice, that framing can make conversations about tobacco more compassionate and more realistic. Rather than assuming that a patient who continues to smoke lacks motivation, providers can explore the barriers that make stopping hard and help identify support that fits the person’s situation.

  • Smoking remains markedly more common among people with HIV than among U.S. adults overall.
  • Longer life expectancy with HIV makes prevention of smoking-related harm increasingly important.
  • Coexisting health conditions can limit the time and attention available for cessation support.
  • Stress, stigma, poverty and loneliness may all complicate attempts to quit.

A public-health success with unfinished work

The progress of HIV treatment should not be overshadowed by this challenge. It is precisely because antiretroviral therapies have changed what living with HIV can look like that reducing smoking-related illness deserves greater attention. The goal is not simply to ask patients to quit more often; it is to make successful quitting more achievable.

For health systems, that means integrating tobacco treatment with the realities of HIV care. For clinicians, it means treating cessation as an ongoing conversation rather than a single intervention. And for public-health programs, it means ensuring that people with HIV have access to multiple, evidence-based options and support that recognizes their distinct needs.

Smoking has declined substantially across the broader U.S. population. Closing the remaining gap for people with HIV will require approaches that match the complexity of the problem—and that build on the gains already achieved in HIV treatment.

This article is based on reporting by Medical Xpress. Read the original article.

Originally published on medicalxpress.com